BVF Inc’s Regulus Therapeutics RGLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-337,621
| Closed | -$4.56M | – | 72 |
|
|
2020
Q4 | $4.56M | Buy |
337,621
+15,873
| +5% | +$117K | 0.18% | 59 |
|
|
2020
Q3 | $1.65M | Buy |
321,748
+176,748
| +122% | +$1.16M | 0.09% | 60 |
|
|
2020
Q2 | $988K | Sell |
145,000
-14,292
| -9% | -$93.5K | 0.06% | 54 |
|
|
2020
Q1 | $734K | Sell |
159,292
-44,278
| -22% | -$386K | 0.07% | 54 |
|
|
2019
Q4 | $1.81M | Hold |
203,570
| – | – | 0.14% | 52 |
|
|
2019
Q3 | $1.47M | Hold |
203,570
| – | – | 0.15% | 54 |
|
|
2019
Q2 | $2.54M | Buy |
203,570
+98,376
| +94% | +$1.13M | 0.28% | 50 |
|
|
2019
Q1 | $1.07M | Hold |
105,194
| – | – | 0.12% | 51 |
|
|
2018
Q4 | $979K | Sell |
105,194
-8,849
| -8% | -$147K | 0.13% | 51 |
|
|
2018
Q3 | $2.7M | Hold |
114,043
| – | – | 0.24% | 51 |
|
|
2018
Q2 | $9.02M | Sell |
114,043
-2,409
| -2% | -$199K | 0.88% | 32 |
|
|
2018
Q1 | $10M | Hold |
116,452
| – | – | 1.02% | 28 |
|
|
2017
Q4 | $14.5M | Buy |
116,452
+8,542
| +8% | +$1.08M | 1.75% | 17 |
|
|
2017
Q3 | $16.2M | Buy |
107,910
+80,586
| +295% | +$10.1M | 2.06% | 18 |
|
|
2017
Q2 | $3.23M | Buy |
27,324
+22,132
| +426% | +$3.69M | 0.5% | 30 |
|
|
2017
Q1 | $1.03M | Buy |
+5,192
| New | +$988K | 0.17% | 30 |
|
|
2014
Q4 | – | Sell |
-1,542
| Closed | -$1.26M | – | 36 |
|
|
2014
Q3 | $1.26M | Hold |
1,542
| – | – | 0.26% | 26 |
|
|
2014
Q2 | $1.49M | Hold |
1,542
| – | – | 0.24% | 26 |
|
|
2014
Q1 | $1.67M | Sell |
1,542
-405
| -21% | -$449K | 0.26% | 24 |
|
|
2013
Q4 | $1.73M | Hold |
1,947
| – | – | 0.3% | 22 |
|
|
2013
Q3 | $2.2M | Sell |
1,947
-273
| -12% | -$322K | 0.38% | 24 |
|
|
2013
Q2 | $2.61M | Buy |
+2,220
| New | +$2.11M | 0.51% | 20 |
|
Other funds holding RGLS
NMC
ECM
ACM
SCM
IC
